Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
41
ICGUF Quote, Financials, Valuation and Earnings
Last price:
$27.72
Seasonality move
:
2.47%
Day range:
$27.72 - $27.72
52-week range:
$25.55 - $27.72
Dividend yield:
4.12%
P/E ratio:
10.42x
P/S ratio:
5.37x
P/B ratio:
2.48x
Volume:
--
Avg. volume:
253
1-year change:
2.15%
Market cap:
$8.1B
Revenue:
$1.3B
EPS (TTM):
$2.66
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, ICG Plc has -- downside to fair value with a price target of -- per share.
ICGUF vs. S&P 500
-
Over the past 5 trading days, ICG Plc has underperformed the S&P 500 by -1.06% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
ICG Plc does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
ICG Plc has grown year-over-year revenues for 0 quarters straight. In the most recent quarter ICG Plc reported revenues of --.
Earnings Growth
-
ICG Plc has grown year-over-year earnings for 0 quarters straight. In the most recent quarter ICG Plc reported earnings per share of --.
Enterprise value:
15.1B
EV / Invested capital:
--
Price / LTM sales:
5.37x
EV / EBIT:
--
EV / Revenue:
12.44x
PEG ratio (5yr expected):
0.32x
EV / Free cash flow:
89.75x
Price / Operating cash flow:
164.43x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$1.5B
Return On Assets:
4.82%
Net Income Margin (TTM):
51.52%
Return On Equity:
18.79%
Return On Invested Capital:
6.95%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2024-02-22 | 2025-02-22 | 2025-02-22 | |||
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -- | -- | -- | -- | -- | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.5B | $1.3B | -- | $1.7B | -- | |
| Total Assets | $11.3B | $9.9B | -- | $12.1B | -- | |
| Current Liabilities | $995.5M | $345.3M | -- | $728.7M | -- | |
| Total Liabilities | $8.9B | $7.8B | -- | $9.1B | -- | |
| Total Equity | $2.4B | $2.1B | -- | $3B | -- | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2024-02-22 | 2025-02-22 | 2025-02-22 | |||
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
ICGUF
Sector
Market Cap
$8.1B
$550.3M
Price % of 52-Week High
100%
91.53%
Dividend Yield
4.12%
1.43%
Shareholder Yield
5%
2.97%
1-Year Price Total Return
2.15%
9.09%
Beta (5-Year)
0.846
0.446
Dividend yield:
4.12%
Annualized payout:
$1.01
Payout ratio:
51.29%
Growth streak:
1 years
Technicals
8-day SMA
Sell
Level
$27.72
200-day SMA
Buy
Level
$27.17
Bollinger Bands (100)
Buy
Level
26.68 - 27.72
Chaikin Money Flow
Sell
Level
--
20-day SMA
Sell
Level
$27.72
Relative Strength Index (RSI14)
Buy
Level
90.20
ADX Line
Neutral
Level
Williams %R
Sell
Level
0
50-day SMA
Buy
Level
$27.02
MACD (12, 26)
Buy
Level
6.18
25-day Aroon Oscillator
Buy
Level
12
On Balance Volume
Neutral
Level
--
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.2283)
Sell
CA Score
(Annual)
Level (-1.2477)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (5)
Sell
Ohlson Score
Level (0.7464)
Buy
Piotroski F Score
(Annual)
Level (5)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
ICG Plc engages in the provision of flexible capital solutions to help companies develop and grow. It is a global alternative asset manager with over 30 years' history, investing across the capital structure. It operates through the Fund Management Company (FMC) and Investment Company (IC) segments. The FMC segment offers investment management services and incurs the majority of the group’s costs in delivering these services. The IC segment recognizes the fair value movement on any hedging derivatives. The company was founded by Andrew Jackson, Thomas Hugh Bartlam, Jean-Loup Brousse de Gersigny, James Odgers, Andrew Coventon Phillips, and Paul J. Piper on March 23, 1988 and is headquartered in London, the United Kingdom.
Stock Forecast FAQ
In the current month, ICGUF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The ICGUF average analyst price target in the past 3 months is --.
-
Where Will ICG Plc Stock Be In 1 Year?
According to analysts, the consensus estimate is that ICG Plc share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About ICG Plc?
Analysts are divided on their view about ICG Plc share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that ICG Plc is a Sell and believe this share price will rise from its current level to --.
-
What Is ICG Plc's Price Target?
The price target for ICG Plc over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is ICGUF A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for ICG Plc is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of ICGUF?
You can purchase shares of ICG Plc via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase ICG Plc shares.
-
What Is The ICG Plc Share Price Today?
ICG Plc was last trading at $27.72 per share. This represents the most recent stock quote for ICG Plc. Yesterday, ICG Plc closed at $27.72 per share.
-
How To Buy ICG Plc Stock Online?
In order to purchase ICG Plc stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get ICGUF Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
ICGUF
Sector
P/E ratio
10.42x
12.49x
PEG ratio
0.32x
0.31x
P/B ratio
2.48x
1.15x
Price / LTM sales
5.37x
1.87x
Growth Metrics
ICGUF
Sector
Revenue growth
--
5.53%
Earnings growth
--
10.36%
Revenue (5-year growth)
80.85%
8.73%
Earnings forecast
--
$0.62
Profitability
ICGUF
Sector
Profitability FY 2024
$1.2B
--
Return on invested capital
6.95%
5.22%
Return on assets
4.82%
1.03%
Return on equity
18.79%
9.95%
Earnings Date
Last Earnings Date
Nov
18
Next Earnings Date
May
21
Estimated Next Earnings Date
Feb
17
Balance Sheet
ICGUF
Sector
Total cash
$782.4M
$418.2M
Short term investments
--
$182.9M
Total assets
$12.1B
$3.1B
Long term debt
--
$57.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Sell
50
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 35x
Sell
40
Is GOOGL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 29x
Alerts
Buy
77
RNG alert for Feb 21
RingCentral, Inc. [RNG] is up 34.37% over the past day.
Sell
9
FROG alert for Feb 21
JFrog Ltd. [FROG] is down 24.98% over the past day.
Buy
72
SNSE alert for Feb 21
Sensei Biotherapeutics, Inc. [SNSE] is up 23.81% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
